Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet complex clinical presentation that often poses a diagnostic challenge. It significantly impairs a patient's quality of life and necessitates a comprehensive approach for effective management.
A thorough history and physical examination form the cornerstone of diagnosing chronic cough. An understanding of the patient's environment, occupational exposures, and lifestyle habits are crucial. The diagnostic algorithm usually involves ruling out common causes such as gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma. If initial investigations fail to identify the cause, more advanced diagnostic modalities, including imaging studies and bronchoscopy, may be warranted.
Empirical therapy can be a valuable tool in the diagnostic process. For instance, a trial of proton pump inhibitors may help diagnose GERD-related cough, while an inhaled corticosteroid trial can indicate asthma as the underlying cause. However, the response to empirical therapy should not replace a thorough diagnostic evaluation.
Despite a comprehensive diagnostic approach, a significant proportion of patients remain with unexplained chronic cough. Such cases necessitate a careful re-evaluation and consideration of less common causes like non-acid reflux, somatic cough syndrome or psychogenic cough. Multidisciplinary collaboration involving pulmonologists, gastroenterologists, otolaryngologists, and behavioral therapists can often provide the best outcomes.
Chronic cough is a multifaceted clinical entity requiring a comprehensive and systematic approach for its effective management. A meticulous history, physical examination, and selective use of diagnostic tests form the foundation of this approach. Empirical therapy can aid in diagnosis but should not replace a thorough evaluation. For refractory cases, a multidisciplinary approach is often beneficial, highlighting the importance of collaborative care in managing this complex condition.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation